Subscribe
The latest psychology and neuroscience discoveries.
My Account
  • Mental Health
  • Social Psychology
  • Cognitive Science
  • Psychopharmacology
  • Neuroscience
  • About
No Result
View All Result
PsyPost
PsyPost
No Result
View All Result
Home Exclusive Psychopharmacology Psychedelic Drugs

Psychedelic use associated with lower odds of heart disease and diabetes, study finds

by Eric W. Dolan
October 11, 2021
in Psychedelic Drugs
Share on TwitterShare on Facebook
Don't miss out! Follow PsyPost on Bluesky!

People who have tried a psychedelic drug at least once in their lifetime have lower odds of heart disease and diabetes, according to new research published in Scientific Reports. The new findings highlight the need for further research to investigate the link between psychedelics and cardiometabolic health.

“In our previous research, we have found associations between lifetime classic psychedelic use and lower odds of being overweight or obese as well as lower odds of having hypertension in the past year, both of which are risk factors of cardiometabolic disease,” said study author Otto Simonsson of the University of Oxford. “We therefore wanted to look specifically at the link between lifetime classic psychedelic use and cardiometabolic diseases such as diabetes and heart disease.”

In an article published in Journal of Psychopharmacology this year, researchers argued “that psychedelic substances such as psilocybin could be used to assist in promoting positive lifestyle change conducive to good overall health,” noting that the use of psychedelic drugs has been associated with spontaneous changes in health-related behaviors, such as reducing alcohol consumption and exercising more.

Simonsson and his colleagues noted in their current study that psychedelics have also “been shown to improve mental health conditions associated with cardiometabolic diseases” and to have some anti-inflammatory properties.

To examine the relationship between psychedelic use and physical health, the researchers examined data from more than 375,000 Americans who had participated in the National Survey on Drug Use and Health, an annual survey sponsored by the U.S. Department of Health and Human Services. Participants reported whether they had ever used the classic psychedelic substances DMT, ayahuasca, LSD, mescaline, peyote or San Pedro, or psilocybin. They also reported whether they had been diagnosed with heart disease or diabetes in the past year.

The researchers found that the prevalence of both conditions was lower among psychedelic users. Approximately 2.3% of those who had ever used a psychedelic reported heart disease in the past year, compared to 4.5% of those who reported never using a psychedelic drug. Similarly, 3.95% of those who had ever used a psychedelic reported diabetes in the past year, compared to 7.7% of those who reported never using a psychedelic drug.

“The findings suggest that lifetime classic psychedelic use is associated with lower odds of having had heart disease or diabetes in the past year,” Simonsson told PsyPost.

The researchers controlled for age, gender, marital status, race, annual household income, level of education, engagement in risky behavior, and the use of other types of drugs. But the findings come with an important caveat.

“The direction of causality remains unknown,” Simonsson said. “Future trials with double-blind, randomized, placebo-controlled designs are needed to establish whether classic psychedelic use may reduce the risk of cardiometabolic diseases and, if so, through which mechanisms.”

The study, “Associations between lifetime classic psychedelic use and cardiometabolic diseases“, was authored by Otto Simonsson, Walter Osika, Robin Carhart-Harris, and Peter S. Hendricks.

TweetSendScanShareSendPin4ShareShareShareShareShare

RELATED

A dose of psilocybin stirred the brain of a barely conscious woman
Neuroimaging

A dose of psilocybin stirred the brain of a barely conscious woman

May 7, 2025

In a groundbreaking case report, scientists administered psilocybin to a woman in a minimally conscious state and observed increased brain complexity and new spontaneous behavior—offering a glimpse into how psychedelics might influence consciousness in severe brain injury patients.

Read moreDetails
Psychedelic users tend to have greater objective knowledge about climate change, study finds
Parkinson's disease

Psilocybin shows promise for improving mood, cognition, and motor symptoms in Parkinson’s disease

May 1, 2025

Psilocybin therapy produced surprising benefits in a small study of people with Parkinson’s disease. Beyond improving mood, the psychedelic treatment was linked to better motor function and cognitive performance.

Read moreDetails
Psychedelic use linked to shifts in sexuality, gender expression, and relationship dynamics, study finds
Psychedelic Drugs

Psychedelic use linked to shifts in sexuality, gender expression, and relationship dynamics, study finds

April 26, 2025

New research shows that psychedelic use is often associated with changes in romantic relationships, sexual experiences, and gender identity. The study highlights how these experiences might foster self-acceptance, authenticity, and greater connection to others.

Read moreDetails
Antidepressant effects of psychedelics may be overstated in some clinical trials
Depression

Antidepressant effects of psychedelics may be overstated in some clinical trials

April 16, 2025

A new meta-analysis shows that reported antidepressant effects of psychedelics vary widely depending on the study design used.

Read moreDetails
Psilocybin-assisted neurofeedback shows promise in preliminary research
Psilocybin

Psilocybin-assisted neurofeedback shows promise in preliminary research

April 3, 2025

A new study explores combining psilocybin microdosing with neurofeedback. The method appears feasible, though it’s unclear whether it meaningfully improves mental performance.

Read moreDetails
Can psychedelics make you a more moral person? New study explores the link
Moral Psychology

Can psychedelics make you a more moral person? New study explores the link

April 3, 2025

A new study suggests that meaningful psychedelic experiences may broaden the range of beings people see as morally worthy.

Read moreDetails
Hallucinogen-related ER visits linked to higher risk of schizophrenia, study finds
Psychedelic Drugs

Hallucinogen-related ER visits linked to higher risk of schizophrenia, study finds

April 2, 2025

A new study suggests that emergency visits involving hallucinogens could be a warning sign for future schizophrenia, especially among younger adults.

Read moreDetails
Is childhood trauma linked to challenging ayahuasca experiences? New study has surprising answer
LSD

New study shows LSD changes brain connectivity in unique ways compared to MDMA and amphetamines

March 27, 2025

A new brain imaging study finds LSD alters brain connectivity in unique ways, setting it apart from MDMA and amphetamine despite some shared effects.

Read moreDetails

SUBSCRIBE

Go Ad-Free! Click here to subscribe to PsyPost and support independent science journalism!

STAY CONNECTED

LATEST

People with lower cognitive ability more likely to fall for pseudo-profound bullshit

Narcissism may be fueling political polarization, according to new psychology research

Scientists studied Fox News — here’s what they discovered

Researchers uncover causal evidence that cannabis legalization reduces problematic consumption

Underweight individuals are at an increased risk of suicide, study finds

Mental illness doesn’t explain who owns or carries guns

Artificial intelligence: 7 eye-opening new scientific discoveries

Children’s facial expressions reveal fear response to gender-nonconforming boys, study finds

         
       
  • Contact us
  • Privacy policy
  • Terms and Conditions
[Do not sell my information]

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

Subscribe
  • My Account
  • Cognitive Science Research
  • Mental Health Research
  • Social Psychology Research
  • Drug Research
  • Relationship Research
  • About PsyPost
  • Contact
  • Privacy Policy